Smith-Lemli-Opitz syndrome (SLOS) is a genetic disorder in which the body cannot properly make cholesterol, leading to a cascade of developmental problems that can range from mild learning difficulties and subtle physical differences to severe, life-threatening birth defects. It is caused by mutations in both copies of a gene called DHCR7, which encodes the enzyme responsible for the final step of cholesterol production. Because cholesterol plays roles far beyond heart health, affecting everything from how embryos develop to how cell membranes function, a shortage during fetal growth can disrupt nearly every organ system.
Why Cholesterol Matters More Than You Think
Most people associate cholesterol with clogged arteries, but in reality, cholesterol is an essential building block of every cell membrane in the body. It is also the raw material for making steroid hormones, bile acids for digesting fat, and certain signaling molecules that guide how an embryo takes shape. In SLOS, the enzyme that converts a precursor molecule called 7-dehydrocholesterol (7-DHC) into cholesterol is missing or barely functional.1PubMed. Mutations in the Delta7-sterol reductase gene in patients with the Smith-Lemli-Opitz syndrome The result is a double problem: cholesterol levels drop far below normal, and 7-DHC piles up to levels roughly a thousand-fold higher than those seen in unaffected people.2PubMed. Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome Both the deficit and the excess cause damage, which is why SLOS affects so many parts of the body at once.
How a Cholesterol Shortage Derails Embryonic Development
One of the most important reasons SLOS causes birth defects is its effect on a signaling system called the Hedgehog pathway. During embryonic development, Hedgehog signals tell cells where they are in the growing body and what they should become, guiding the formation of the brain, face, limbs, and internal organs. A key protein in this pathway, called Smoothened, requires cholesterol to work correctly. When cholesterol is too low, Smoothened cannot activate properly or move to the right spot on the cell surface, and the signaling chain breaks down.3PubMed Central. Reduced cholesterol levels impair Smoothened activation in Smith–Lemli–Opitz syndrome Research in mouse models has confirmed that falling sterol levels progressively weaken the Hedgehog response, and the malformations seen in SLOS closely match the types of defects you would expect when this pathway is disrupted.4Nature Genetics. A defective response to Hedgehog signaling in disorders of cholesterol biosynthesis
This connection explains why so many SLOS features cluster in midline structures. The brain, face, palate, and genitalia all rely heavily on Hedgehog-directed patterning during early weeks of pregnancy, which is why these are the areas most frequently affected.
Physical Features and the Wide Severity Spectrum
SLOS ranges dramatically in severity. At one end are individuals with relatively mild features: perhaps some learning difficulties, behavioral quirks, and subtle physical findings that may not be recognized until adulthood. At the other end are cases so severe that they are lethal before or shortly after birth.5The American Journal of Human Genetics. Mutational Spectrum in the Δ7-Sterol Reductase Gene and Genotype-Phenotype Correlation in 84 Patients with Smith-Lemli-Opitz Syndrome In one series of 49 confirmed cases, half had either been terminated or died during infancy.6Journal of Medical Genetics. Smith-Lemli-Opitz syndrome: a variable clinical and biochemical phenotype
The most recognizable external features include a small head with a characteristic facial appearance, cleft palate, extra fingers or toes on the pinky side of the hand, and webbing between the second and third toes. Males often have underdeveloped genitalia.7PubMed. Smith-Lemli-Opitz syndrome: phenotype, natural history, and epidemiology Internal malformations can involve the heart, kidneys, and brain. In a study of fetal cases, heart septal defects and kidney anomalies were especially common.8PubMed Central. Smith-Lemli-Opitz syndrome – Fetal phenotypes with special reference to the syndrome-specific internal malformation pattern
Mild cases can be surprisingly difficult to spot. A report describing the oldest known patient, a 73-year-old woman, documented only partial toe syndactyly, a wide forehead, a triangular face, mild intellectual disability, and recurrent hip dislocations. These features had never prompted genetic testing until late in life.9PubMed Central. Smith-Lemli-Opitz Syndrome with Biallelic c.1295A>G (p.Tyr432Cys) Variant in the DHCR7 Gene in a 73-Year-Old Woman: Report of the Oldest Patient This underscores how wide the clinical spectrum truly is and why the condition is probably underdiagnosed in its mildest forms.
Brain Abnormalities and Cognitive Effects
Brain involvement is nearly universal. In a study of 55 patients who underwent brain imaging, 96% had abnormalities. The most common finding was an abnormal septum pellucidum, the thin membrane separating the brain’s front fluid-filled chambers, seen in about three-quarters of patients. Problems with the corpus callosum, the major fiber bundle connecting the brain’s two hemispheres, appeared in roughly 70%. Other findings included brain tissue shrinkage, cysts, and a condition called holoprosencephaly, where the brain fails to divide into two hemispheres properly.10PubMed Central. Brain magnetic resonance imaging findings in Smith-Lemli-Opitz syndrome Frontal lobe underdevelopment and problems with the migration of nerve cells to their correct positions have also been reported.11PubMed. MRI in Smith-Lemli-Opitz syndrome type I
On the cognitive and behavioral side, most individuals with SLOS have some degree of intellectual disability, and delays in language and motor skills are the norm. But the behavioral profile is what often draws the most attention from families. Sensory over-reactivity, where ordinary sounds, textures, or lights become overwhelming, is common and can drive self-injurious behaviors like head-banging or skin-picking. Sleep problems, hyperactivity, and difficulty regulating emotions are also frequently reported.12American Journal of Medical Genetics Part C: Seminars in Medical Genetics. Cognitive and behavioral aspects of Smith-Lemli-Opitz syndrome
A finding that has drawn particular research interest is the overlap with autism spectrum disorder. When researchers used standard autism diagnostic instruments, most SLOS participants scored above the clinical threshold, yet only about half actually received a clinical diagnosis of autism.13PubMed Central. Development, behavior, and biomarker characterization of Smith-Lemli-Opitz syndrome: an update This gap suggests that SLOS produces behaviors that look like autism on screening tests but may arise from different underlying mechanisms, making it a useful condition for researchers trying to untangle the biology of autism-like traits.
Photosensitivity and Skin Reactions
Many children with SLOS develop painful sunburn-like reactions after exposure to sunlight, even through window glass. The culprit is not 7-DHC itself, which does not absorb the relevant wavelengths of light. Instead, 7-DHC gets converted in the body to a metabolite that strongly absorbs ultraviolet A light. When this metabolite is hit by UVA, it generates bursts of reactive oxygen species, essentially free radicals that damage and kill skin cells. In laboratory experiments, skin cells exposed to this metabolite and then hit with UVA showed an 88% drop in survival compared to cells kept in the dark.14Free Radical Biology and Medicine. Ultraviolet A sensitivity in Smith-Lemli-Opitz syndrome: Possible involvement of cholesta-5,7,9(11)-trien-3 beta-ol This explains why families are often advised to use UVA-blocking sunscreens and protective clothing, and it also connects to the broader interest in antioxidant treatments discussed below.
Eyes, Hormones, and the Immune System
Cholesterol is a major component of the eye’s lens and retinal membranes, so it is not surprising that SLOS affects vision. Drooping eyelids are the single most common eye finding, but cataracts, optic nerve underdevelopment, crossed eyes, and involuntary eye movements have all been documented. Retinal abnormalities have been noted even in infancy, and abnormally low cholesterol concentrations have been measured in all ocular tissues studied.15PubMed. Ocular manifestations of the Smith-Lemli-Opitz syndrome Eye exams in early life are an important part of managing the condition.
The hormonal impact of SLOS flows directly from cholesterol’s role as the starting material for steroid hormones. Cortisol, aldosterone, and sex hormones are all synthesized from cholesterol. In severe cases, the adrenal glands may fail to produce enough cortisol and aldosterone, creating a life-threatening salt-wasting crisis in the first days of life.16Hormone Research. Adrenal Insufficiency and Abnormal Genitalia in a 46XX Female with Smith-Lemli-Opitz Syndrome This hormonal disruption also explains why genital development is often affected in both sexes, though it is more outwardly visible in males.
Children with SLOS tend to get frequent respiratory infections. For a long time, this was attributed to muscle weakness and poor respiratory effort rather than to an immune problem per se. But evidence is accumulating that cholesterol is actually needed for normal immune cell function. At least one patient has been documented with a selective antibody deficiency, meaning the immune system did not produce certain protective antibodies normally.17PubMed. Selective antibody immune deficiency in a patient with Smith-Lemli-Opitz syndrome Research using SLOS models has found that sterol biosynthesis appears to be required for normal innate immune responses, the body’s first-line defense against pathogens.18The Journal of Immunology. Smith-Lemli-Opitz syndrome reveals requirement for sterol biosynthesis in the innate immune response This means the frequent infections in SLOS are probably not just a side effect of being immobile or weak but reflect a genuine immune vulnerability.
How SLOS Is Diagnosed
The biochemical hallmark of SLOS is elevated 7-DHC in the blood, often accompanied by low cholesterol. In unaffected people, 7-DHC is essentially undetectable, but in SLOS patients it can reach concentrations comparable to normal cholesterol levels.19PubMed. Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome Measuring 7-DHC in a blood sample is the standard diagnostic test, and specialized mass spectrometry methods can detect it with high sensitivity.20Clinical Chemistry. Smith-Lemli-Opitz syndrome diagnosed by using time-of-flight secondary-ion mass spectrometry Genetic testing of the DHCR7 gene confirms the diagnosis and identifies the specific mutations, which can help with genetic counseling for future pregnancies.
Prenatal suspicion sometimes arises when a routine second-trimester blood screen shows unusually low levels of unconjugated estriol, a hormone made by the placenta using fetal cholesterol. If the fetus cannot make enough cholesterol, estriol production drops. However, low estriol is not specific to SLOS and can occur for other reasons, so the finding needs to be followed up with targeted biochemical or genetic testing.21PubMed. Recognition of Smith-Lemli-Opitz syndrome (RSH) in the fetus: utility of ultrasonography and biochemical analysis in pregnancies with low maternal serum estriol Ultrasound may reveal some of the structural abnormalities, but milder cases can slip through even when anomalies are present, because SLOS is not always on the clinician’s radar as a possible diagnosis.22PubMed. Recognition of Smith-Lemli-Opitz syndrome (RSH) in the fetus: utility of ultrasonography and biochemical analysis in pregnancies with low maternal serum estriol Because SLOS follows autosomal recessive inheritance, each subsequent pregnancy in the same family carries a one-in-four chance of being affected, making early testing in known carrier families especially valuable.
Treatment Approaches and Their Limits
The most intuitive treatment for a cholesterol deficiency is to supply more cholesterol. In practice, this means giving children cholesterol-rich foods like egg yolks or a purified cholesterol suspension. Dietary cholesterol supplementation has been a mainstay of SLOS management for decades, and many clinicians report improvements in growth and general well-being. However, the evidence for rapid behavioral benefits is weaker than early reports suggested. A controlled trial in ten patients found no measurable differences in behavior between the treatment and placebo periods, despite using conditions similar to those in earlier anecdotal reports.23PubMed Central. Analysis of short-term behavioral effects of dietary cholesterol supplementation in Smith-Lemli-Opitz syndrome A major limitation of dietary cholesterol is that it does not cross the blood-brain barrier well, so it may improve things in the body while having limited direct impact on the brain.
This is where simvastatin enters the picture. Statins are normally used to lower cholesterol, which sounds counterproductive for SLOS. But simvastatin, which does cross into the brain, has been proposed to work through a different mechanism in SLOS: it may boost the expression of partially functional DHCR7 enzyme from certain milder mutations, coaxing the body to convert more of the toxic 7-DHC into cholesterol.24Genetics in Medicine. A placebo-controlled trial of simvastatin therapy in Smith-Lemli-Opitz syndrome In a placebo-controlled trial with 18 patients, simvastatin lowered the ratio of toxic cholesterol precursors to total sterols in the blood, with the precursor fraction dropping from about 9% to about 6%.25PubMed Central. A Placebo-Controlled Trial of Simvastatin Therapy in Smith-Lemli-Opitz Syndrome Whether this biochemical improvement translates into meaningful clinical benefits over the long term is still being studied, and simvastatin is not appropriate for every patient, particularly those whose mutations leave no residual enzyme activity to boost.
Antioxidants as an Emerging Strategy
One of the more promising research directions targets the toxic byproducts of 7-DHC rather than trying to fix cholesterol levels directly. 7-DHC is the most oxidation-prone lipid known in biology. It reacts readily with oxygen to produce a family of oxysterols that damage cell membranes and alter gene expression. This oxidative damage is now thought to contribute to many SLOS symptoms independently of the cholesterol shortage itself.
In cell culture experiments, treating SLOS skin cells with an antioxidant mixture, particularly vitamin E, reduced levels of a key toxic oxysterol and helped normalize gene expression patterns that had been disrupted.26Biological Psychiatry. Antioxidant Supplementation Ameliorates Molecular Deficits in Smith-Lemli-Opitz Syndrome When pregnant mice carrying SLOS pups were fed vitamin E-enriched diets, the newborn pups had lower oxysterol levels in their brains and livers. Research has further shown that antioxidants can suppress the formation of these harmful oxysterols in SLOS cell models, validating the idea that oxidative stress is a measurable and targetable part of the disease.27Journal of Lipid Research. 7-Dehydrocholesterol-derived oxysterols are elevated in Smith-Lemli-Opitz syndrome models and are suppressed by an antioxidant Early clinical results combining cholesterol supplementation with antioxidant therapy have been described as encouraging.28PubMed Central. Antioxidants: The Missing Key to Improved Therapeutic Intervention in Smith-Lemli-Opitz Syndrome?
The antioxidant angle also connects back to the photosensitivity problem. If UVA-triggered free radical damage in the skin is driven by oxysterols derived from 7-DHC, then antioxidants might reduce skin reactions too. This has not yet been rigorously tested in clinical trials, but the logic is consistent with the biochemistry.
Carrier Frequency and Why SLOS May Be More Common Than It Seems
SLOS is classified as a rare disease, with clinical estimates suggesting it affects somewhere around 1 in 20,000 to 1 in 60,000 live births in populations of European descent. But carrier frequency studies have consistently found that the rate of people carrying one mutated copy of DHCR7 is higher than you would expect given how rarely the syndrome is diagnosed, roughly 1 in 30 in some European-ancestry populations. If you do the math, that carrier rate predicts more affected births than actually show up in clinical registries. The most likely explanation is that many of the most severely affected pregnancies end in early miscarriage before a diagnosis can be made, and the mildest cases, like the 73-year-old woman described earlier, go unrecognized throughout life.29PubMed. The Smith-Lemli-Opitz syndrome: a novel metabolic way of understanding developmental biology, embryogenesis, and dysmorphology This gap between expected and observed cases makes SLOS one of the more intriguing discrepancies in human genetics.
The discovery of the biochemical basis of SLOS in the 1990s was itself a turning point. Before researchers connected the syndrome to cholesterol, it was known only to a small group of specialists who recognized the pattern of physical features. Identifying the enzyme defect and the gene behind it opened the door to biochemical testing, prenatal screening, and the treatment strategies now being refined. It also established that inborn errors of cholesterol metabolism could cause malformation syndromes, a concept that has since expanded to related conditions involving other steps in the same biochemical pathway.